Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 201 articles:
HTML format
Text format



Single Articles


    May 2018
  1. WAN J, Ling X, Peng B, Ding G, et al
    miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6439.
    PubMed     Text format     Abstract available


  2. LIN C, Qin Y, Zhang H, Gao MY, et al
    EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in nonsmall cell lung cancer cells.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6417.
    PubMed     Text format     Abstract available


  3. WANG M, Liu Y, Qian X, Wei N, et al
    Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma.
    Oncol Rep. 2018 May 2. doi: 10.3892/or.2018.6408.
    PubMed     Text format     Abstract available


  4. PAN Y, Wang H, Ma D, Ji Z, et al
    miR24 may be a negative regulator of menin in lung cancer.
    Oncol Rep. 2018;39:2342-2350.
    PubMed     Text format     Abstract available


  5. XU S, Yang F, Liu R, Li X, et al
    Serum microRNA-139-5p is downregulated in lung cancer patients with lytic bone metastasis.
    Oncol Rep. 2018;39:2376-2384.
    PubMed     Text format     Abstract available


  6. LI Y, Wei Y, Yuan W, Huang Q, et al
    DNA damage induced by human CD40 ligand mutant promotes senescence and induces demethylation of GATA4 in lung cancer.
    Oncol Rep. 2018;39:2071-2080.
    PubMed     Text format     Abstract available


    April 2018
  7. DING J, Jia X, Zuo B, He J, et al
    A novel monoclonal antibody targeting a novel epitope of VEcadherin inhibits vasculogenic mimicry of lung cancer cells.
    Oncol Rep. 2018 Apr 16. doi: 10.3892/or.2018.6374.
    PubMed     Text format     Abstract available


  8. LIU L, Han C, Yu H, Zhu W, et al
    Chloroquine inhibits cell growth in human A549 lung cancer cells by blocking autophagy and inducing mitochondrialmediated apoptosis.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6363.
    PubMed     Text format     Abstract available


    March 2018
  9. MA Y, Wu X, Xiu Z, Liu X, et al
    Cytochalasin H isolated from mangrovederived endophytic fungus induces apoptosis and inhibits migration in lung cancer cells.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6347.
    PubMed     Text format     Abstract available


  10. PARK BR, Lee SA, Moon SM, Kim CS, et al
    Anthricininduced caspasedependent apoptosis through IGF1R/PI3K/AKT pathway inhibition in A549 human nonsmall lung cancer cells.
    Oncol Rep. 2018 Mar 27. doi: 10.3892/or.2018.6333.
    PubMed     Text format     Abstract available


    February 2018
  11. WANG Q, Chen Y, Feng H, Zhang B, et al
    Prognostic and predictive value of HURP in nonsmall cell lung cancer.
    Oncol Rep. 2018 Feb 26. doi: 10.3892/or.2018.6280.
    PubMed     Text format     Abstract available


  12. BAEK JH, Yim JH, Song JY, Um HD, et al
    Knockdown of end-binding protein 1 induces apoptosis in radioresistant A549 lung cancer cells via p38 kinase-dependent COX-2 upregulation.
    Oncol Rep. 2018 Feb 22. doi: 10.3892/or.2018.6278.
    PubMed     Text format     Abstract available


  13. TIAN H, Yin L, Ding K, Xia YY, et al
    Raf1 is a prognostic factor for progression in patients with nonsmall cell lung cancer after radiotherapy.
    Oncol Rep. 2018 Feb 22. doi: 10.3892/or.2018.6277.
    PubMed     Text format     Abstract available


  14. LIU J, Xing Y, Rong L
    miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.
    Oncol Rep. 2018 Feb 13. doi: 10.3892/or.2018.6268.
    PubMed     Text format     Abstract available


  15. KEERATICHAMROEN S, Lirdprapamongkol K, Svasti J
    Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells.
    Oncol Rep. 2018 Feb 12. doi: 10.3892/or.2018.6258.
    PubMed     Text format     Abstract available


  16. CHANG WA, Yen MC, Hung JY, Yang CJ, et al
    Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer.
    Oncol Rep. 2018;39:573-581.
    PubMed     Text format     Abstract available


    January 2018
  17. HU Y, Li X, Lin L, Liang S, et al
    Puerarin inhibits non-small cell lung cancer cell growth via the induction of apoptosis.
    Oncol Rep. 2018 Jan 26. doi: 10.3892/or.2018.6234.
    PubMed     Text format     Abstract available


  18. SEO YS, Kang OH, Kong R, Zhou T, et al
    Polygalacin D induces apoptosis and cell cycle arrest via the PI3K/Akt pathway in non-small cell lung cancer.
    Oncol Rep. 2018 Jan 23. doi: 10.3892/or.2018.6230.
    PubMed     Text format     Abstract available


  19. LI B, Ding CM, Li YX, Peng JC, et al
    Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Oncol Rep. 2018 Jan 15. doi: 10.3892/or.2018.6215.
    PubMed     Text format     Abstract available


  20. KANAJI N, Kamitori K, Hossain A, Noguchi C, et al
    Additive antitumour effect of Dallose in combination with cisplatin in non-small cell lung cancer cells.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6192.
    PubMed     Text format     Abstract available


  21. LIU F, Gao S, Yang Y, Zhao X, et al
    Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6188.
    PubMed     Text format     Abstract available


  22. FU S, Liu C, Huang Q, Fan S, et al
    Estrogen receptor beta1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6186.
    PubMed     Text format     Abstract available


  23. TANG Z, Shen Q, Xie H, Zhou Z, et al
    Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and gamma-ray irradiation was elucidated.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6181.
    PubMed     Text format     Abstract available


    December 2017
  24. ZHAO L, Liu L, Dong Z, Xiong J, et al
    miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
    Oncol Rep. 2017;38:3522-3530.
    PubMed     Text format     Abstract available


    November 2017
  25. TANG C, Luo H, Luo D, Yang H, et al
    Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6109.
    PubMed     Text format     Abstract available


  26. LI Y, Hu T, Chen T, Yang T, et al
    Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6111.
    PubMed     Text format     Abstract available


  27. PARK WH
    MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6107.
    PubMed     Text format     Abstract available


  28. ZHANG C, Xiao X, Chen M, Aldharee H, et al
    Liver kinase B1 restoration promotes exosome secretion and motility of lung cancer cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6085.
    PubMed     Text format     Abstract available


  29. JIMENEZ-HERNANDEZ LE, Vazquez-Santillan K, Castro-Oropeza R, Martinez-Ruiz G, et al
    NRP1-positive lung cancer cells possess tumor-initiating properties.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6089.
    PubMed     Text format     Abstract available


  30. YANG L, Zha TQ, He X, Chen L, et al
    Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6086.
    PubMed     Text format     Abstract available


  31. WANG H, Zhang Y, Wu Q, Wang YB, et al
    miR-16 mimics inhibit TGF-beta1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6088.
    PubMed     Text format     Abstract available


    October 2017
  32. NI X, Cao X, Wu Y, Wu J, et al
    FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.
    Oncol Rep. 2017 Oct 31. doi: 10.3892/or.2017.6061.
    PubMed     Text format     Abstract available


  33. XU Z, Xu J, Lu H, Lin B, et al
    LARP1 is regulated by the XIST/miR-374a axis and functions as an oncogene in non-small cell lung carcinoma.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6040.
    PubMed     Text format     Abstract available


  34. ZHANG C, Yu P, Zhu L, Zhao Q, et al
    Blockade of alpha7 nicotinic acetylcholine receptors inhibit nicotine-induced tumor growth and vimentin expression in non-small cell lung cancer through MEK/ERK signaling way.
    Oncol Rep. 2017 Oct 2. doi: 10.3892/or.2017.6014.
    PubMed     Text format     Abstract available


    September 2017
  35. QIU X, Guan X, Liu W, Zhang Y, et al
    DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6000.
    PubMed     Text format     Abstract available


  36. XU M, Tang X, Guo J, Sun W, et al
    Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6002.
    PubMed     Text format     Abstract available


  37. WANG RH, Cao HM, Tian ZJ, Jin B, et al
    [Retracted] Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6006.
    PubMed     Text format     Abstract available


  38. WEI Y, Li D, Wang D, Qiu T, et al
    Evaluation of microRNA-203 in bone metastasis of patients with non-small cell lung cancer through TGF-beta/SMAD2 expression.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5987.
    PubMed     Text format     Abstract available


  39. TIAN C, Li J, Ren L, Peng R, et al
    MicroRNA-381 serves as a prognostic factor and inhibits migration and invasion in non-small cell lung cancer by targeting LRH-1.
    Oncol Rep. 2017 Sep 14. doi: 10.3892/or.2017.5956.
    PubMed     Text format     Abstract available


  40. HAN Z, Zhou X, Li S, Qin Y, et al
    Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5938.
    PubMed     Text format     Abstract available


    August 2017
  41. KONG R, Liu W, Guo Y, Feng J, et al
    Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Oncol Rep. 2017 Aug 28. doi: 10.3892/or.2017.5927.
    PubMed     Text format     Abstract available


  42. FUNAKI S, Shintani Y, Kawamura T, Kanzaki R, et al
    Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-beta induced epithelial mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017 Aug 9. doi: 10.3892/or.2017.5894.
    PubMed     Text format     Abstract available


  43. TANG T, Huan L, Zhang S, Zhou H, et al
    MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5885.
    PubMed     Text format     Abstract available


    July 2017
  44. WANG D, Cao Q, Qu M, Xiao Z, et al
    MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7.
    Oncol Rep. 2017 Jul 28. doi: 10.3892/or.2017.5854.
    PubMed     Text format     Abstract available


  45. ZHOU F, Nie L, Feng D, Guo S, et al
    MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF1R-mediated AKT and ERK pathways.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5835.
    PubMed     Text format     Abstract available


  46. WANG Y, Zhao M, Liu J, Sun Z, et al
    miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3beta signaling pathway.
    Oncol Rep. 2017 Jul 12. doi: 10.3892/or.2017.5808.
    PubMed     Text format     Abstract available


  47. HONG CF, Chen WY, Wu CW
    Upregulation of Wnt signaling under hypoxia promotes lung cancer progression.
    Oncol Rep. 2017 Jul 12. doi: 10.3892/or.2017.5807.
    PubMed     Text format     Abstract available


    June 2017
  48. KIM GT, Kim SY, Kim YM
    Torilis japonica extract fraction compound, EGFR-targeted inhibition of cancer abnormal metastasis in A549 lung cancer cells.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5771.
    PubMed     Text format     Abstract available


  49. ZHANG Z, Rui W, Wang ZC, Liu DX, et al
    Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
    Oncol Rep. 2017 Jun 27. doi: 10.3892/or.2017.5760.
    PubMed     Text format     Abstract available


  50. TANG Y, He R, An J, Deng P, et al
    lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP.
    Oncol Rep. 2017 Jun 26. doi: 10.3892/or.2017.5751.
    PubMed     Text format     Abstract available


  51. XU Z, Yan Y, Zeng S, Qian L, et al
    Reducing autophagy and inducing G1 phase arrest by aloperine enhances radio-sensitivity in lung cancer cells.
    Oncol Rep. 2017 Jun 19. doi: 10.3892/or.2017.5732.
    PubMed     Text format     Abstract available


  52. ZENG Y, Zhu J, Qin H, Shen D, et al
    Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5690.
    PubMed     Text format     Abstract available


  53. XU W, Wu B, Fu L, Chen J, et al
    Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.
    Oncol Rep. 2017;37:3219-3226.
    PubMed     Text format     Abstract available


  54. SEIKE M, Kim CH, Zou F, Noro R, et al
    AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
    Oncol Rep. 2017;37:3261-3269.
    PubMed     Text format     Abstract available


    May 2017
  55. SCHLUCKEBIER L, Aran V, De Moraes J, Paiva H, et al
    XAF1 expression levels in a non-small cell lung cancer cohort and its potential association with carcinogenesis.
    Oncol Rep. 2017 May 30. doi: 10.3892/or.2017.5680.
    PubMed     Text format     Abstract available


  56. LIU L, Xiao L, Liang X, Chen L, et al
    TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer.
    Oncol Rep. 2017 May 11. doi: 10.3892/or.2017.5638.
    PubMed     Text format     Abstract available


  57. TANG F, Hu P, Yang Z, Xue C, et al
    SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.
    Oncol Rep. 2017 May 10. doi: 10.3892/or.2017.5635.
    PubMed     Text format     Abstract available


  58. LI GJ, Zhao GQ, Yang JP, Zhou YC, et al
    Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5624.
    PubMed     Text format     Abstract available


  59. YE Z, Fang B, Pan J, Zhang N, et al
    miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
    Oncol Rep. 2017 May 3. doi: 10.3892/or.2017.5619.
    PubMed     Text format     Abstract available


  60. YAN J, Ma C, Gao Y
    MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines.
    Oncol Rep. 2017;37:3146-3154.
    PubMed     Text format     Abstract available


  61. WANG J, Wang Y, Sun D, Ren F, et al
    CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017;37:3068-3074.
    PubMed     Text format     Abstract available


  62. CHEN G, Yu H, Satherley L, Zabkiewicz C, et al
    The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer.
    Oncol Rep. 2017;37:2695-2701.
    PubMed     Text format     Abstract available


  63. CAI Y, Ruan J, Yao X, Zhao L, et al
    MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.
    Oncol Rep. 2017;37:2787-2794.
    PubMed     Text format     Abstract available


  64. SUZAWA K, Yamamoto H, Ohashi K, Hashida S, et al
    Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.
    Oncol Rep. 2017;37:3100-3106.
    PubMed     Text format     Abstract available


  65. WANG X, Li M, Hu M, Wei P, et al
    BAMBI overexpression together with beta-sitosterol ameliorates NSCLC via inhibiting autophagy and inactivating TGF-beta/Smad2/3 pathway.
    Oncol Rep. 2017;37:3046-3054.
    PubMed     Text format     Abstract available


    April 2017
  66. ZHANG Y, Sui J, Shen X, Li C, et al
    Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Oncol Rep. 2017 Apr 28. doi: 10.3892/or.2017.5612.
    PubMed     Text format     Abstract available


  67. WANG H, Zhan Y, Jin J, Zhang C, et al
    MicroRNA-15b promotes proliferation and invasion of nonsmall cell lung carcinoma cells by directly targeting TIMP2.
    Oncol Rep. 2017 Apr 26. doi: 10.3892/or.2017.5604.
    PubMed     Text format     Abstract available


  68. YOO HS, Kim JM, Jo E, Cho CK, et al
    Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells.
    Oncol Rep. 2017 Apr 20. doi: 10.3892/or.2017.5590.
    PubMed     Text format     Abstract available


  69. WANG W, Zhang L, Liu L, Zheng Y, et al
    Chemosensitizing effect of shRNA-mediated ERCC1 silencing on a Xuanwei lung adenocarcinoma cell line and its clinical significance.
    Oncol Rep. 2017;37:1989-1997.
    PubMed     Text format     Abstract available


  70. SHEN F, Long D, Yu T, Chen X, et al
    Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
    Oncol Rep. 2017;37:2481-2489.
    PubMed     Text format     Abstract available


  71. ZHANG R, Gu J, Chen J, Ni J, et al
    High expression of PINK1 promotes proliferation and chemoresistance of NSCLC.
    Oncol Rep. 2017;37:2137-2146.
    PubMed     Text format     Abstract available


  72. CHENG R, Lu C, Zhang G, Zhang G, et al
    Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
    Oncol Rep. 2017;37:2129-2136.
    PubMed     Text format     Abstract available


    March 2017
  73. ZHANG L, Xiao X, An H, Wang J, et al
    Inhibition of CCR7 promotes NF-kappaB-dependent apoptosis and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017 Mar 23. doi: 10.3892/or.2017.5524.
    PubMed     Text format     Abstract available


  74. XIANG GL, Zhu XH, Lin CZ, Wang LJ, et al
    125I seed irradiation induces apoptosis and inhibits angiogenesis by decreasing HIF-1alpha and VEGF expression in lung carcinoma xenografts.
    Oncol Rep. 2017 Mar 23. doi: 10.3892/or.2017.5521.
    PubMed     Text format     Abstract available


  75. YANG N, Liang Y, Yang P, Ji F, et al
    Propofol suppresses LPS-induced nuclear accumulation of HIF-1alpha and tumor aggressiveness in non-small cell lung cancer.
    Oncol Rep. 2017 Mar 17. doi: 10.3892/or.2017.5514.
    PubMed     Text format     Abstract available


  76. SU J, Yan Y, Qu J, Xue X, et al
    Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-kappaB pathway.
    Oncol Rep. 2017;37:1565-1572.
    PubMed     Text format     Abstract available


  77. LI K, Yang M, Liang N, Li S, et al
    Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review).
    Oncol Rep. 2017;37:1347-1358.
    PubMed     Text format     Abstract available


  78. CHOI YJ, Kim JH, Rho JK, Kim JS, et al
    AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5482.
    PubMed     Text format     Abstract available


  79. MA J, Li J, Yao X, Lin S, et al
    FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5483.
    PubMed     Text format     Abstract available


  80. YANG JS, Lin CA, Lu CC, Wen YF, et al
    Carboxamide analog ITR-284 evokes apoptosis and inhibits migration ability in human lung adenocarcinoma A549 cells.
    Oncol Rep. 2017;37:1786-1792.
    PubMed     Text format     Abstract available


  81. TIETJE A, Yang X, Yu X, Wei Y, et al
    MICA/IL-12: A novel bifunctional protein for killer cell activation.
    Oncol Rep. 2017;37:1889-1895.
    PubMed     Text format     Abstract available


    February 2017
  82. CHEN S, Jiang S, Hu F, Xu Y, et al
    Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Oncol Rep. 2017 Feb 16. doi: 10.3892/or.2017.5461.
    PubMed     Text format     Abstract available


  83. GUO Y, Sun W, Gong T, Chai Y, et al
    miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5448.
    PubMed     Text format     Abstract available


  84. GUO CY, Yan C, Luo L, Goto S, et al
    Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5438.
    PubMed     Text format     Abstract available


  85. KAKE S, Usui T, Ohama T, Yamawaki H, et al
    Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Oncol Rep. 2017;37:1100-1106.
    PubMed     Text format     Abstract available


  86. CHEN T, Gong W, Tian H, Wang H, et al
    Fibroblast growth factor 18 promotes proliferation and migration of H460 cells via the ERK and p38 signaling pathways.
    Oncol Rep. 2017;37:1235-1242.
    PubMed     Text format     Abstract available


  87. KIM MH, Jeong YJ, Cho HJ, Hoe HS, et al
    Delphinidin inhibits angiogenesis through the suppression of HIF-1alpha and VEGF expression in A549 lung cancer cells.
    Oncol Rep. 2017;37:777-784.
    PubMed     Text format     Abstract available


  88. ZHANG B, Zhang Y, Yu D
    Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Oncol Rep. 2017;37:937-944.
    PubMed     Text format     Abstract available


  89. LIN D, Kuang G, Wan J, Zhang X, et al
    Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression.
    Oncol Rep. 2017;37:895-902.
    PubMed     Text format     Abstract available


    January 2017
  90. WANG J, Song J, Gao Z, Huo X, et al
    Analysis of gene expression profiles of non-small cell lung cancer at different stages reveals significantly altered biological functions and candidate genes.
    Oncol Rep. 2017 Jan 17. doi: 10.3892/or.2017.5380.
    PubMed     Text format     Abstract available


  91. LIU X, Wu X, Ma Y, Zhang W, et al
    Endophytic fungi from mangrove inhibit lung cancer cell growth and angiogenesis in vitro.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5366.
    PubMed     Text format     Abstract available


  92. QIN Q, Wei F, Zhang J, Li B, et al
    miR-134 suppresses the migration and invasion of nonsmall cell lung cancer by targeting ITGB1.
    Oncol Rep. 2017 Jan 3. doi: 10.3892/or.2017.5350.
    PubMed     Text format     Abstract available


  93. ZHOU Y, Ma J, Zhang J, He L, et al
    Pifithrin-mu is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Oncol Rep. 2017;37:313-322.
    PubMed     Text format     Abstract available


  94. LI Z, Li B, Niu L, Ge L, et al
    miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.
    Oncol Rep. 2017;37:297-304.
    PubMed     Text format     Abstract available


  95. GONG L, Zhou X, Yang J, Jiang Y, et al
    Effects of the regulation of polysialyltransferase ST8SiaII on the invasiveness and metastasis of small cell lung cancer cells.
    Oncol Rep. 2017;37:131-138.
    PubMed     Text format     Abstract available


    December 2016
  96. SHEN H, Wang L, Zhang J, Dong W, et al
    ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response.
    Oncol Rep. 2016 Dec 28. doi: 10.3892/or.2016.5337.
    PubMed     Text format     Abstract available


  97. LEE YJ, Lim T, Han MS, Lee SH, et al
    Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.
    Oncol Rep. 2016 Dec 23. doi: 10.3892/or.2016.5336.
    PubMed     Text format     Abstract available


  98. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available


  99. XU J, Wu W, Wang J, Huang C, et al
    miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5314.
    PubMed     Text format     Abstract available


  100. WANG M, Wang Q, Peng WJ, Hu JF, et al
    Testin is a tumor suppressor in non-small cell lung cancer.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5316.
    PubMed     Text format     Abstract available


  101. XIE S, Tu Z, Xiong J, Kang G, et al
    CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Oncol Rep. 2016 Dec 2. doi: 10.3892/or.2016.5289.
    PubMed     Text format     Abstract available


  102. ASAKA S, Yoshizawa A, Matsuda K, Yamaguchi A, et al
    A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
    Oncol Rep. 2016 Dec 2. doi: 10.3892/or.2016.5287.
    PubMed     Text format     Abstract available


  103. WEN R, Xiao Y, Zhang Y, Yang M, et al
    Identification of a novel transcript isoform of the TTLL12 gene in human cancers.
    Oncol Rep. 2016;36:3172-3180.
    PubMed     Text format     Abstract available


  104. LU X, Guo H, Chen X, Xiao J, et al
    Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-beta1 in lung adenocarcinoma cells.
    Oncol Rep. 2016;36:3105-3112.
    PubMed     Text format     Abstract available


    November 2016
  105. GU S, Zhang R, Gu J, Li X, et al
    HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5268.
    PubMed     Text format     Abstract available


  106. LIU T, Yin H
    PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer.
    Oncol Rep. 2016 Nov 16. doi: 10.3892/or.2016.5253.
    PubMed     Text format     Abstract available


  107. KRASKO JA, Zilionyte K, Darinskas A, Strioga M, et al
    Bacterial ghosts as adjuvants in syngeneic tumour cell lysate-based anticancer vaccination in a murine lung carcinoma model.
    Oncol Rep. 2016 Nov 16. doi: 10.3892/or.2016.5252.
    PubMed     Text format     Abstract available


  108. KIM JH, Kim MS, Lee BH, Kim JK, et al
    Marmesin-mediated suppression of VEGF/VEGFR and integrin beta1 expression: Its implication in non-small cell lung cancer cell responses and tumor angiogenesis.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5245.
    PubMed     Text format     Abstract available


  109. WANG D, Ma J, Ji X, Xu F, et al
    miR-141 regulation of EIF4E expression affects docetaxel chemoresistance of non-small cell lung cancer.
    Oncol Rep. 2016 Nov 2. doi: 10.3892/or.2016.5214.
    PubMed     Text format     Abstract available


  110. XU L, Yan Y, Xue X, Li CG, et al
    Angiogenin elevates the invasive potential of squamous cell lung carcinoma cells through epithelialmesenchymal transition.
    Oncol Rep. 2016;36:2836-2842.
    PubMed     Text format     Abstract available


  111. JANG IS, Park JW, Jo EB, Cho CK, et al
    Growth inhibitory and apoptosis-inducing effects of allergen-free Rhus verniciflua Stokes extract on A549 human lung cancer cells.
    Oncol Rep. 2016;36:3037-3043.
    PubMed     Text format     Abstract available


  112. SHE K, Huang J, Zhou H, Huang T, et al
    lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression.
    Oncol Rep. 2016;36:2673-2680.
    PubMed     Text format     Abstract available


  113. OLBROMSKI M, Grzegrzolka J, Jankowska-Konsur A, Witkiewicz W, et al
    MicroRNAs modulate the expression of the SOX18 transcript in lung squamous cell carcinoma.
    Oncol Rep. 2016;36:2884-2892.
    PubMed     Text format     Abstract available


  114. CHEN J, Lu X, Lu C, Wang C, et al
    13-Methyl-palmatrubine induces apoptosis and cell cycle arrest in A549 cells in vitro and in vivo.
    Oncol Rep. 2016;36:2526-2534.
    PubMed     Text format     Abstract available


    October 2016
  115. YAO J, Ma C, Gao W, Liang J, et al
    Fentanyl induces autophagy via activation of the ROS/MAPK pathway and reduces the sensitivity of cisplatin in lung cancer cells.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5183.
    PubMed     Text format     Abstract available


  116. CHEN X, Li Q, Kan XX, Wang YJ, et al
    Extract of Caulis Spatholobi, a novel blocker targeting tumor cellinduced platelet aggregation, inhibits breast cancer metastasis.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5184.
    PubMed     Text format     Abstract available


  117. LI G, He Y, Yao J, Huang C, et al
    Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathways.
    Oncol Rep. 2016 Oct 12. doi: 10.3892/or.2016.5166.
    PubMed     Text format     Abstract available


  118. LIU Y, Miao L, Ni R, Zhang H, et al
    microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.
    Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5149.
    PubMed     Text format     Abstract available


  119. CHEN YH, Zhou BY, Wu XJ, Xu JF, et al
    CCL22 and IL-37 inhibit the proliferation and epithelial-mesenchymal transition process of NSCLC A549 cells.
    Oncol Rep. 2016;36:2017-24.
    PubMed     Text format     Abstract available


  120. WANG X, Liu Y, Dai L, Liu Q, et al
    Foxp3 downregulation in NSCLC mediates epithelial-mesenchymal transition via NF-kappaB signaling.
    Oncol Rep. 2016;36:2282-8.
    PubMed     Text format     Abstract available


  121. ZHUANG X, Qiao T, Xu G, Yuan S, et al
    Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
    Oncol Rep. 2016;36:2200-6.
    PubMed     Text format     Abstract available


    September 2016
  122. PENG J, Liu HZ, Zhong J, Deng ZF, et al
    MicroRNA187 is an independent prognostic factor in lung cancer and promotes lung cancer cell invasion via targeting of PTRF.
    Oncol Rep. 2016 Sep 12. doi: 10.3892/or.2016.5083.
    PubMed     Text format     Abstract available


  123. ZHAO H, Xue J, Liu J, Liu Y, et al
    Effect of metastasis suppressor 1 on H1299 cells and its clinical significance in non-small cell lung cancer.
    Oncol Rep. 2016 Sep 12. doi: 10.3892/or.2016.5081.
    PubMed     Text format     Abstract available


  124. SHI H, Ji Y, Zhang D, Liu Y, et al
    MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells.
    Oncol Rep. 2016 Sep 5. doi: 10.3892/or.2016.5063.
    PubMed     Text format     Abstract available


  125. UTHAISAR K, Vaeteewoottacharn K, Seubwai W, Talabnin C, et al
    Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.
    Oncol Rep. 2016;36:1435-46.
    PubMed     Text format     Abstract available


  126. CHENG Q, Zhou L, Zhou J, Wan H, et al
    ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC.
    Oncol Rep. 2016;36:1403-10.
    PubMed     Text format     Abstract available


  127. UGUEN A, Andrieu-Key S, Vergne F, Descourt R, et al
    ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues.
    Oncol Rep. 2016;36:1427-34.
    PubMed     Text format     Abstract available


  128. CHEN J, Hu L, Chen J, Wu F, et al
    Low expression lncRNA RPLP0P2 is associated with poor prognosis and decreased cell proliferation and adhesion ability in lung adenocarcinoma.
    Oncol Rep. 2016;36:1665-71.
    PubMed     Text format     Abstract available


    August 2016
  129. LIU L, Mei Q, Zhao J, Dai Y, et al
    Suppression of CEP55 reduces cell viability and induces apoptosis in human lung cancer.
    Oncol Rep. 2016 Aug 31. doi: 10.3892/or.2016.5059.
    PubMed     Text format     Abstract available


  130. ZHANG J, Yamada O, Kida S, Matsushita Y, et al
    Identification of brefelamide as a novel inhibitor of osteopontin that suppresses invasion of A549 lung cancer cells.
    Oncol Rep. 2016 Aug 5. doi: 10.3892/or.2016.5006.
    PubMed     Text format     Abstract available


  131. DU H, Huang Y, Hou X, Yu X, et al
    DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment.
    Oncol Rep. 2016;36:721-8.
    PubMed     Text format     Abstract available


  132. FAN Z, Jiang H, Wang Z, Qu J, et al
    Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-beta1 by attenuating the upregulation of SphK1.
    Oncol Rep. 2016;36:1016-22.
    PubMed     Text format     Abstract available


  133. WAN J, Wu W, Huang Y, Ge W, et al
    Incomplete radiofrequency ablation accelerates proliferation and angiogenesis of residual lung carcinomas via HSP70/HIF-1alpha.
    Oncol Rep. 2016;36:659-68.
    PubMed     Text format     Abstract available


  134. CHEN Q, Hu H, Jiao D, Yan J, et al
    miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
    Oncol Rep. 2016;36:909-17.
    PubMed     Text format     Abstract available


  135. BAO Z, Lu G, Cui D, Yao Y, et al
    IL-17A-producing T cells are associated with the progression of lung adenocarcinoma.
    Oncol Rep. 2016;36:641-50.
    PubMed     Text format     Abstract available


    July 2016
  136. XIONG J, Wu JS, Mao SS, Yu XN, et al
    Effect of saracatinib on pulmonary metastases from hepatocellular carcinoma.
    Oncol Rep. 2016 Jul 22. doi: 10.3892/or.2016.4968.
    PubMed     Text format     Abstract available


  137. HU P, He J, Liu S, Wang M, et al
    beta2-adrenergic receptor activation promotes the proliferation of A549 lung cancer cells via the ERK1/2/CREB pathway.
    Oncol Rep. 2016 Jul 22. doi: 10.3892/or.2016.4966.
    PubMed     Text format     Abstract available


  138. SUNG WJ, Kim H, Park KK
    The biological role of epithelial-mesenchymal transition in lung cancer (Review).
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4964.
    PubMed     Text format     Abstract available


  139. CHEN X, Wei L, Zhao S
    miR-338 inhibits the metastasis of lung cancer by targeting integrin beta3.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4928.
    PubMed     Text format     Abstract available


  140. OU Y, Ho WS
    Crocodile blood extract induces the apoptosis of lung cancer cells through PTEN activity.
    Oncol Rep. 2016 Jul 5. doi: 10.3892/or.2016.4914.
    PubMed     Text format     Abstract available


  141. WU HJ, Wu HB, Zhao YQ, Chen LJ, et al
    Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion.
    Oncol Rep. 2016;36:324-32.
    PubMed     Text format     Abstract available


  142. WANG Z, Tang F, Hu P, Wang Y, et al
    HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma.
    Oncol Rep. 2016;36:589-97.
    PubMed     Text format     Abstract available


  143. WANG J, Weng Y, Zhang M, Li Y, et al
    BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cellderived microenvironment through the MAPK/ERK and NF-kappaB pathways.
    Oncol Rep. 2016;36:410-8.
    PubMed     Text format     Abstract available


  144. DUAN Q, Pang C, Chang N, Zhang J, et al
    Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition.
    Oncol Rep. 2016;36:551-8.
    PubMed     Text format     Abstract available


  145. LI JY, Yu J, Du XS, Zhang HM, et al
    Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway.
    Oncol Rep. 2016;36:147-54.
    PubMed     Text format     Abstract available


  146. KIM KH, Chae JI, Oh H, Cho JH, et al
    Manumycin A induces apoptosis in malignant pleural mesothelioma through regulation of Sp1 and activation of the mitochondria-related apoptotic pathway.
    Oncol Rep. 2016;36:117-24.
    PubMed     Text format     Abstract available


    June 2016
  147. YE H, Wei X, Wang Z, Zhang S, et al
    A novel double carbonyl analog of curcumin induces the apoptosis of human lung cancer H460 cells via the activation of the endoplasmic reticulum stress signaling pathway.
    Oncol Rep. 2016 Jun 30. doi: 10.3892/or.2016.4911.
    PubMed     Text format     Abstract available


  148. LIU M, Sun W, Liu Y, Dong X, et al
    The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
    Oncol Rep. 2016 Jun 29. doi: 10.3892/or.2016.4909.
    PubMed     Text format     Abstract available


  149. SUN Y, Han Y, Wang X, Wang W, et al
    Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer.
    Oncol Rep. 2016 Jun 23. doi: 10.3892/or.2016.4905.
    PubMed     Text format     Abstract available


  150. WEI XH, Lin SS, Liu Y, Zhao RP, et al
    DT-13 attenuates human lung cancer metastasis via regulating NMIIA activity under hypoxia condition.
    Oncol Rep. 2016 Jun 16. doi: 10.3892/or.2016.4879.
    PubMed     Text format     Abstract available


  151. GIANNINI R, Lupi C, Sensi E, Ali G, et al
    EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center.
    Oncol Rep. 2016 Jun 14. doi: 10.3892/or.2016.4874.
    PubMed     Text format     Abstract available


  152. ZHANG NH, Peng RQ, Ding Y, Zhang XS, et al
    Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells.
    Oncol Rep. 2016 Jun 13. doi: 10.3892/or.2016.4870.
    PubMed     Text format     Abstract available


  153. SHEN L, Yang M, Lin Q, Zhang Z, et al
    COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
    Oncol Rep. 2016 Jun 10. doi: 10.3892/or.2016.4869.
    PubMed     Text format     Abstract available


  154. JIN G, Jin M, Jin Z, Gao Z, et al
    Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer.
    Oncol Rep. 2016 Jun 8. doi: 10.3892/or.2016.4863.
    PubMed     Text format     Abstract available


  155. NAMBU J, Kobayashi T, Hashimoto M, Tashiro H, et al
    h-prune affects anaplastic thyroid cancer invasion and metastasis.
    Oncol Rep. 2016;35:3445-52.
    PubMed     Text format     Abstract available


  156. WU Y, Yu DD, Hu Y, Yan D, et al
    Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray.
    Oncol Rep. 2016;35:3371-86.
    PubMed     Text format     Abstract available


  157. HAN X, Tian Y, Tian D
    Tumor metastatic promoter ABCE1 interacts with the cytoskeleton protein actin and increases cell motility.
    Oncol Rep. 2016;35:3623-9.
    PubMed     Text format     Abstract available


    May 2016
  158. WANG J, Wan X, Gao Y, Zhong M, et al
    Latcripin-13 domain induces apoptosis and cell cycle arrest at the G1 phase in human lung carcinoma A549 cells.
    Oncol Rep. 2016 May 23. doi: 10.3892/or.2016.4830.
    PubMed     Text format     Abstract available


  159. HU CF, Huang YY, Wang YJ, Gao FG, et al
    Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells.
    Oncol Rep. 2016 May 23. doi: 10.3892/or.2016.4827.
    PubMed     Text format     Abstract available


  160. TU Z, He D, Deng X, Xiong M, et al
    An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer.
    Oncol Rep. 2016 May 18. doi: 10.3892/or.2016.4817.
    PubMed     Text format     Abstract available


  161. WAN Z, Jiang D, Chen S, Jiao J, et al
    T-box transcription factor brachyury promotes tumor cell invasion and metastasis in non-small cell lung cancer via upregulation of matrix metalloproteinase 12.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4792.
    PubMed     Text format     Abstract available


  162. ITO T, Ozaki S, Chanasong R, Mizutani Y, et al
    Activation of ERK/IER3/PP2A-B56gamma-positive feedback loop in lung adenocarcinoma by allelic deletion of B56gamma gene.
    Oncol Rep. 2016;35:2635-42.
    PubMed     Text format     Abstract available


  163. SUN M, Hong S, Li W, Wang P, et al
    MiR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4.
    Oncol Rep. 2016;35:2755-66.
    PubMed     Text format     Abstract available


  164. WANG X, Liu Y, Liu X, Yang J, et al
    MiR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma.
    Oncol Rep. 2016;35:3115-21.
    PubMed     Text format     Abstract available


    April 2016
  165. JIANG ZB, Huang J, Xie C, Li X, et al
    Combined use of PI3K and MEK inhibitors synergistically inhibits lung cancer with EGFR and KRAS mutations.
    Oncol Rep. 2016 Apr 26. doi: 10.3892/or.2016.4770.
    PubMed     Text format     Abstract available


  166. QIAO WL, Hu HY, Shi BW, Zang LJ, et al
    Lentivirus-mediated knockdown of TSP50 suppresses the growth of non-small cell lung cancer cells via G0/G1 phase arrest.
    Oncol Rep. 2016 Apr 20. doi: 10.3892/or.2016.4763.
    PubMed     Text format     Abstract available


  167. FENG C, Liu X, Li X, Guo F, et al
    Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutations.
    Oncol Rep. 2016 Apr 13. doi: 10.3892/or.2016.4741.
    PubMed     Text format     Abstract available


  168. LEE YS, Doonan BB, Wu JM, Hsieh TC, et al
    Combined metformin and resveratrol confers protection against UVC-induced DNA damage in A549 lung cancer cells via modulation of cell cycle checkpoints and DNA repair.
    Oncol Rep. 2016 Apr 11. doi: 10.3892/or.2016.4740.
    PubMed     Text format     Abstract available


  169. ANDREASEN S, Persson M, Kiss K, Homoe P, et al
    Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland.
    Oncol Rep. 2016;35:2177-82.
    PubMed     Text format     Abstract available


  170. GUO B, Li X, Song S, Chen M, et al
    (-)-beta-hydrastine suppresses the proliferation and invasion of human lung adenocarcinoma cells by inhibiting PAK4 kinase activity.
    Oncol Rep. 2016;35:2246-56.
    PubMed     Text format     Abstract available


  171. WANG Y, Han R, Chen Z, Fu M, et al
    A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
    Oncol Rep. 2016;35:2257-69.
    PubMed     Text format     Abstract available


    March 2016
  172. LI J, Guan J, Long X, Wang Y, et al
    mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance.
    Oncol Rep. 2016 Mar 29. doi: 10.3892/or.2016.4714.
    PubMed     Text format     Abstract available


  173. ZHOU L, Di Q, Sun B, Wang X, et al
    MicroRNA-194 restrains the cell progression of non-small cell lung cancer by targeting human nuclear distribution protein C.
    Oncol Rep. 2016 Mar 28. doi: 10.3892/or.2016.4708.
    PubMed     Text format     Abstract available


  174. WANG R, Ma L, Weng D, Yao J, et al
    Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Oncol Rep. 2016 Mar 17. doi: 10.3892/or.2016.4690.
    PubMed     Text format     Abstract available


  175. SHI S, Tan P, Yan B, Gao R, et al
    ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells.
    Oncol Rep. 2016 Mar 16. doi: 10.3892/or.2016.4680.
    PubMed     Text format     Abstract available


  176. SHEN L, Yang M, Lin Q, Zhang Z, et al
    SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer.
    Oncol Rep. 2016 Mar 10. doi: 10.3892/or.2016.4670.
    PubMed     Text format     Abstract available


  177. DA C, Liu Y, Zhan Y, Liu K, et al
    Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-beta1/Smad3 signaling pathway.
    Oncol Rep. 2016 Mar 7. doi: 10.3892/or.2016.4661.
    PubMed     Text format     Abstract available


  178. REN B, Wei X, Zou G, He J, et al
    Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer.
    Oncol Rep. 2016 Mar 1. doi: 10.3892/or.2016.4645.
    PubMed     Text format     Abstract available


    February 2016
  179. ZHANG W, Liang Z, Li J
    Inhibition of rhotekin exhibits antitumor effects in lung cancer cells.
    Oncol Rep. 2016 Feb 24. doi: 10.3892/or.2016.4634.
    PubMed     Text format     Abstract available


  180. XU YZ, Li YH, Lu WJ, Lu K, et al
    YL4073 is a potent autophagy-stimulating antitumor agent in an in vivo model of Lewis lung carcinoma.
    Oncol Rep. 2016 Feb 1. doi: 10.3892/or.2016.4603.
    PubMed     Text format     Abstract available


  181. HE Z, Huang C, Lin G, Ye Y, et al
    siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
    Oncol Rep. 2016 Feb 1. doi: 10.3892/or.2016.4602.
    PubMed     Text format     Abstract available


    January 2016
  182. LI M, Li JJ, Gu QH, An J, et al
    EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4587.
    PubMed     Text format     Abstract available


  183. WANG Y, Kong H, Zeng X, Liu W, et al
    Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells.
    Oncol Rep. 2016 Jan 18. doi: 10.3892/or.2016.4569.
    PubMed     Text format     Abstract available


  184. TIAN W, Liu J, Pei B, Wang X, et al
    Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer.
    Oncol Rep. 2016 Jan 14. doi: 10.3892/or.2016.4561.
    PubMed     Text format     Abstract available


  185. KONG R, Feng J, Ma Y, Zhou B, et al
    Silencing NACK by siRNA inhibits tumorigenesis in non-small cell lung cancer via targeting Notch1 signaling pathway.
    Oncol Rep. 2016 Jan 13. doi: 10.3892/or.2016.4552.
    PubMed     Text format     Abstract available


  186. WU TT, Lu CL, Lin HI, Chen BF, et al
    beta-Elemonic acid inhibits the cell proliferation of human lung adenocarcinoma A549 cells: The role of MAPK, ROS activation and glutathione depletion.
    Oncol Rep. 2016;35:227-34.
    PubMed     Text format     Abstract available


  187. ATZIN-MENDEZ JA, Lopez-Gonzalez JS, Baez R, Arenas-Del Angel MC, et al
    Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-beta2 microglobulin complexes.
    Oncol Rep. 2016;35:33-42.
    PubMed     Text format     Abstract available


    December 2015
  188. WAN J, Wu W, Zhang R
    Local recurrence of small cell lung cancer following radiofrequency ablation is induced by HIF1alpha expression in the transition zone.
    Oncol Rep. 2015 Dec 31. doi: 10.3892/or.2015.4541.
    PubMed     Text format     Abstract available


  189. SMARDOVA J, Liskova K, Ravcukova B, Malcikova J, et al
    Complex analysis of the p53 tumor suppressor in lung carcinoma.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4533.
    PubMed     Text format     Abstract available


  190. ZHAO W, Wang J, Zhu B, Duan Y, et al
    IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Oncol Rep. 2015 Dec 24. doi: 10.3892/or.2015.4516.
    PubMed     Text format     Abstract available


  191. MA L, Li P, Wang R, Nan Y, et al
    Analysis of novel microRNA targets in drug-sensitive and -insensitive small cell lung cancer cell lines.
    Oncol Rep. 2015 Dec 16. doi: 10.3892/or.2015.4487.
    PubMed     Text format     Abstract available


    November 2015
  192. YAKISICH JS, Azad N, Venkatadri R, Kulkarni Y, et al
    Digitoxin and its synthetic analog MonoD have potent antiproliferative effects on lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel.
    Oncol Rep. 2015 Nov 12. doi: 10.3892/or.2015.4416.
    PubMed     Text format     Abstract available


    June 2015
  193. GUO W, Zhang S, Liu S
    Establishment of a novel orthotopic model of breast cancer metastasis to the lung.
    Oncol Rep. 2015;33:2992-8.
    PubMed     Text format     Abstract available


    May 2015
  194. ZHANG X, Zheng L, Sun Y, Wang T, et al
    Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells.
    Oncol Rep. 2015 May 15. doi: 10.3892/or.2015.3982.
    PubMed     Text format     Abstract available


  195. ZHANG X, Teng Y, Yang F, Wang M, et al
    MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
    Oncol Rep. 2015;33:2599-605.
    PubMed     Text format     Abstract available


  196. NAZIM UM, Jeong JK, Seol JW, Hur J, et al
    Inhibition of the autophagy flux by gingerol enhances TRAIL-induced tumor cell death.
    Oncol Rep. 2015;33:2331-6.
    PubMed     Text format     Abstract available


  197. TSUJI AB, Sugyo A, Sudo H, Suzuki C, et al
    Preclinical assessment of early tumor response after irradiation by positron emission tomography with 2-amino-[3-(1)(1)C]isobutyric acid.
    Oncol Rep. 2015;33:2361-7.
    PubMed     Text format     Abstract available


    April 2015
  198. PICKARSKI M, Gleason A, Bednar B, Duong LT, et al
    Orally active alphavbeta3 integrin inhibitor MK0429 reduces melanoma metastasis.
    Oncol Rep. 2015 Apr 9. doi: 10.3892/or.2015.3910.
    PubMed     Text format     Abstract available


  199. HIRATA T, Zheng Q, Chen Z, Kinoshita H, et al
    Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma.
    Oncol Rep. 2015;33:2052-60.
    PubMed     Text format     Abstract available


  200. TONG Y, Yue J, Mao M, Liu Q, et al
    Recombinant nematode anticoagulant protein c2 inhibits cell invasion by decreasing uPA expression in NSCLC cells.
    Oncol Rep. 2015;33:1815-22.
    PubMed     Text format     Abstract available


    February 2015
  201. WOO JK, Kang JH, Jang YS, Ro S, et al
    Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment
    Oncol Rep. 2015 Feb 10. doi: 10.3892/or.2015.3793.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: